A concept for integrated care pathways for atopic dermatitis—A GA2LEN ADCARE initiative

Abstract

Introduction The integrated care pathways for atopic dermatitis (AD-ICPs) aim to bridge the gap between existing AD treatment evidence-based guidelines and expert opinion based on daily practice by offering a structured multidisciplinary plan for patient management of AD. ICPs have the potential to enhance guideline recommendations by combining interventions and aspects from different guidelines, integrating quality assurance, and describing co-ordination of care. Most importantly, patients can enter the ICPs at any level depending on AD severity, resources available in their country, and economic factors such as differences in insurance reimbursement systems.

Methods The GA2LEN ADCARE network and partners as well as all stakeholders, abbreviated as the AD-ICPs working group, were involved in the discussion and preparation of the AD ICPs during a series of subgroup workshops and meetings in years 2020 and 2021, after which the document was circulated within all GAL2EN ADCARE centres.

Results The AD-ICPs outline the diagnostic procedures, possible co-morbidities, different available treatment options including differential approaches for the pediatric population, and the role of the pharmacists and other stakeholders, as well as remaining unmet needs in the management of AD.

Conclusion The AD-ICPs provide a multidisciplinary plan for improved diagnosis, treatment, and patient feedback in AD management, as well as addressing critical unmet needs, including improved access to care, training specialists, implementation of educational programs, assessment on the impact of climate change, and fostering a personalised treatment approach. By focusing on these key areas, the initiative aims to pave the way for a brighter future in the management of AD.

Metadata

Item Type:	Article
Authors/Creators:	Zuberbier, T. https://orcid.org/0000-0002-1466-8875 Abdul Latiff, A. Aggelidis, X. https://orcid.org/0000-0003-1715-3022 Augustin, M. Balan, R. Bangert, C. Beck, L. Bieber, T. Bernstein, J.A. Bertolin Colilla, M. Berardi, A. Bedbrook, A. Bindslev‐Jensen, C. https://orcid.org/0000-0002-8940-038X Bousquet, J. https://orcid.org/0000-0002-4061-4766 de Bruin‐Weller, M. Bruscky, D. Buyuktiryaki, B. https://orcid.org/0000-0003-1206-969X Canonica, G.W. Castro, C. Chanturidze, N. Chong‐Neto, H.J. Chu, C. Chularojanamontri, L. Cork, M. Criado, R.F.J. https://orcid.org/0000-0003-2482-3047 Barredo, L.C. Custovic, A. Darsow, U. Emurlai, A. de Pablo, A. Del Giacco, S. Girolomoni, G. Deleva Jovanova, T. Deleuran, M. Douladiris, N. Duarte, B. Dubakiene, R. Eller, E. Engel‐Yeger, B. Ensina, L.F. Filho, N.R. Flohr, C. Fomina, D. Francuzik, W. Galimberti, M.L. Giménez‐Arnau, A.M. https://orcid.org/0000-0001-5434-7753 Godse, K. Mortz, C.G. Gotua, M. Hide, M. Hoetzenecker, W. Hunzelmann, N. Irvine, A. Jack, C. Kanavarou, I. Katoh, N. Kinaciyan, T. Kocatürk, E. Kulthanan, K. Lapeere, H. Lau, S. Machado Forti Nastri, M. Makris, M. Mansour, E. https://orcid.org/0000-0001-6450-6930 Marsland, A. Morelo Rocha Felix, M. Moschione Castro, A.P. Nettis, E. Nicolas, J.F. Nosbaum, A. Odemyr, M. Papapostolou, N. Parisi, C.A.S. Paudel, S. Peter, J. https://orcid.org/0000-0002-2658-0723 Pokharel, P. Puig, L. Quint, T. Ramon, G.D. Regateiro, F. Ricci, G. Rosario, C. Sackesen, C. Schmid‐Grendelmeier, P. Serra‐Baldrich, E. Siemens, K. Smith, C. Staubach, P. Stevanovic, K. Su‐Kücük, Ö Sussman, G. Tavecchio, S. Teovska Mitrevska, N. Thaci, D. Toubi, E. Traidl‐Hoffmann, C. Treudler, R. Vadasz, Z. van Hofman, I. Ventura, M.T. Wang, Z. Werfel, T. Wollenberg, A. Yang, A. Weng Yew, Y. Zhao, Z. https://orcid.org/0000-0002-9595-6050 Zwiener, R. https://orcid.org/0000-0001-9636-6741 Worm, M. https://orcid.org/0000-0002-3449-1245
Copyright, Publisher and Additional Information:	© 2023 The Authors. Clinical and Translational Allergy published by John Wiley & Sons Ltd on behalf of European Academy of Allergy and Clinical Immunology. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited: https://creativecommons.org/licenses/by/4.0/
Keywords:	ICP; atopic dermatitis; eczema; guidance; integrated care pathways; multidisciplinary; prevention; treatment
Dates:	Published: September 2023 Published (online): 14 September 2023 Accepted: 23 August 2023
Institution:	The University of Sheffield
Academic Units:	The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > Department of Infection, Immunity and Cardiovascular Disease
Depositing User:	Symplectic Sheffield
Date Deposited:	09 Oct 2023 10:56
Last Modified:	09 Oct 2023 10:56
Published Version:	http://dx.doi.org/10.1002/clt2.12299
Status:	Published
Publisher:	Wiley
Refereed:	Yes
Identification Number:	10.1002/clt2.12299
Related URLs:	PubMed URL
Open Archives Initiative ID (OAI ID):	oai:eprints.whiterose.ac.uk:204061

CORE (COnnecting REpositories)

A concept for integrated care pathways for atopic dermatitis—A GA2LEN ADCARE initiative

Abstract

Metadata

Download

Published Version

Export

Statistics